The F900 is the Most Capable System on the Market for Companies Who Need Large, 3D-Printed Production Parts in Small or Large Volume.Continue reading
Category Archives: AZBio News
Roche launches VENTANA PD-L1 (SP142) Assay in CE markets as first companion diagnostic to identify triple-negative breast cancer patients eligible for treatment with Tecentriq
This launch represents an important step in Roche’s personalised healthcare strategy to fit treatments to patients who can benefit most from a specific medicine.
Each year 300,000 patients around the world are diagnosed with triple-negative breast cancer, an aggressive disease with limited treatment options1,2
VENTANA PD-L1 (SP142) Assay helps identify triple-negative breast cancer patients most likely to benefit from treatment with Tecentriq plus chemotherapy
OncoMyx Therapeutics, Inc. to be honored with an AZBio Fast Lane Award
CHANDLER, Ariz — (BUSINESS WIRE) — The Arizona Bioindustry Association (AZBio) today announced that OncoMyx Therapeutics, Inc. has been named an AZBio Fast Lane Company and will be honored on October 2, 2019 at the AZBio Awards.Continue reading
GT Medical Technologies, Inc. to be honored with an AZBio Fast Lane Award
CHANDLER, Ariz — (BUSINESS WIRE) — The Arizona Bioindustry Association (AZBio) today announced that GT Medical Technologies, Inc. (GT MedTech) has been named an AZBio Fast Lane Company and will be honored on October 2, 2019 at the AZBio Awards.Continue reading
Arizona Bioscience Week: Life Changing Innovation in the 48th State
CHANDLER, Ariz — (BUSINESS WIRE) — The Arizona Bioindustry Association (AZBio) today announced the final line up for the fourth annual Arizona Bioscience Week which will begin on September 30, 2019 and conclude on October 4, 2019.Continue reading
Aqualung Therapeutics Corporation Receives NIH Grant
AQUALUNG THERAPEUTICS CORPORATION receives a $225,000 National Institutes of Health (NIH) (award number R41 HL147769-01) Grant to establish a novel panel of Acute Respiratory Distress Syndrome (ARDS) biomarkers (CRIT-ICU Panel) that stratifies subjects at risk for ARDS into high and low mortality sub-groups.
UA Physiology Research Identifies Brain Inflammation As Potential Target to Treat Tinnitus
The discovery by Dr. Shaowen Bao and his colleagues could lead to new treatments to silence tinnitus for millions of sufferers.Continue reading
Debbie McCune Davis to be honored with AZBio Pubic Service Award
The Arizona Bioindustry Association (AZBio) today announced that the Honorable Debbie McCune Davis, Executive Director of The Arizona Partnership for Immunization will receive the AZBio Public Service Award in recognition of her accomplishments during four decades of service to the community at the AZBio Awards on October 2, 2019.Continue reading